Kintegral Advisory LLC Sells 21,911 Shares of CVS Health Corporation (NYSE:CVS)

Kintegral Advisory LLC reduced its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 32.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 44,670 shares of the pharmacy operator's stock after selling 21,911 shares during the quarter. Kintegral Advisory LLC's holdings in CVS Health were worth $3,026,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Dodge & Cox lifted its holdings in CVS Health by 11.2% during the 4th quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock valued at $3,147,054,000 after purchasing an additional 7,075,209 shares during the last quarter. Capital World Investors lifted its stake in shares of CVS Health by 26.6% during the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock worth $2,739,927,000 after buying an additional 12,819,148 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of CVS Health by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock worth $1,211,582,000 after buying an additional 689,867 shares during the period. Capital International Investors grew its stake in CVS Health by 4.8% in the 4th quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock valued at $1,196,989,000 after buying an additional 1,212,126 shares during the last quarter. Finally, Pzena Investment Management LLC raised its holdings in CVS Health by 49.3% in the 4th quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock valued at $880,319,000 after acquiring an additional 6,475,271 shares during the period. Institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Cowen restated a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Wells Fargo & Company reaffirmed an "overweight" rating and issued a $84.00 price target (up from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Jefferies Financial Group raised their price target on shares of CVS Health from $74.00 to $80.00 and gave the stock a "buy" rating in a research note on Monday. Finally, Barclays set a $79.00 price target on CVS Health and gave the company an "overweight" rating in a research report on Monday, June 2nd. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $75.06.

Insider Activity

In other CVS Health news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the acquisition, the director owned 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Trading Up 1.2%

Shares of NYSE CVS traded up $0.78 during midday trading on Friday, reaching $67.38. The company had a trading volume of 3,770,987 shares, compared to its average volume of 10,832,881. The stock has a market cap of $85.23 billion, a PE ratio of 16.08, a price-to-earnings-growth ratio of 0.97 and a beta of 0.57. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The firm's fifty day moving average price is $65.06 and its 200-day moving average price is $61.31. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. The business's quarterly revenue was up 7.0% compared to the same quarter last year. On average, equities research analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.